Darren R Feldman
Overview
Explore the profile of Darren R Feldman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
177
Citations
5662
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gleeson J, Knezevic A, Bromberg M, Patil S, Sheinfeld J, Carver B, et al.
J Clin Oncol
. 2025 Mar;
:JCO2500475.
PMID: 40085809
No abstract available.
2.
Pal S, Powles T, Kanesvaran R, Molina-Cerrillo J, Feldman D, Barata P, et al.
Future Oncol
. 2025 Feb;
21(7):787-794.
PMID: 40008409
Management of advanced non-clear cell renal cell carcinoma (nccRCC) is challenging due to disease rarity and heterogeneity. The combination of multi-targeted tyrosine kinase inhibitor (TKI) with immune checkpoint inhibitor (ICI)...
3.
Kerns S, Dinh Jr P, Monahan P, Stump T, Fung C, Sesso H, et al.
J Natl Cancer Inst
. 2025 Feb;
PMID: 39898813
Background: To comprehensively evaluate the longitudinal progression of cumulative burden of morbidity (CBM) in testicular cancer survivors (TCS) following standard-dose cisplatin-chemotherapy and the impact of modifiable risk factors on morbidity...
4.
Baky F, Matulewicz R, Knezevic A, Hossain J, Williams B, Lee A, et al.
BJU Int
. 2025 Jan;
PMID: 39789892
No abstract available.
5.
Tateo V, Thompson Z, Gilbert S, Cortessis V, Daneshmand S, Masterson T, et al.
Eur Urol
. 2024 Nov;
PMID: 39542769
Background And Objective: Testicular germ cell tumors (TGCTs) are globally rare, although incidence significantly varies across global geographic regions and ethnicities. Recent decades have seen an unexplained increase in incidence....
6.
Fitzgerald K, Lee C, Voss M, Carlo M, Knezevic A, Peralta L, et al.
Eur Urol
. 2024 Oct;
87(1):96.
PMID: 39426859
No abstract available.
7.
Baky F, Liso N, Williams B, Knezevic A, Funt S, Feldman D, et al.
Clin Genitourin Cancer
. 2024 Sep;
22(6):102217.
PMID: 39307609
Background: Patients who undergo primary retroperitoneal lymph node dissection (pRPLND) for early-stage testicular cancer and have no cancer (pN0) found in the retroperitoneum are believed to have an excellent prognosis....
8.
Matulewicz R, Baky F, Knezevic A, Sheinfeld J, Williams B, Kantor R, et al.
Eur Urol Open Sci
. 2024 Sep;
68:1-9.
PMID: 39257620
Background: MicroRNAs (miRNAs) show promise as blood-based tumor markers for germ cell tumors (GCTs), with miRNA-371-3p being the most studied. The marginal benefit of including other candidate miRNAs to aid...
9.
Dinh Jr P, Monahan P, Fung C, Sesso H, Feldman D, Vaughn D, et al.
JNCI Cancer Spectr
. 2024 Aug;
8(5).
PMID: 39141447
No study has comprehensively examined associated factors (adverse health outcomes, health behaviors, and demographics) affecting cognitive function in long-term testicular cancer survivors (TC survivors). TC survivors given cisplatin-based chemotherapy completed...
10.
Baky F, Liso N, Williams B, Reuter V, Tickoo S, Feldman D, et al.
Urology
. 2024 Aug;
193:174-179.
PMID: 39128634
Objective: To review the presentation and long-term oncologic outcomes of patients with regressed ("burnt out") primary testicular germ cell tumors (GCT). Certain testicular GCT can present with complete regression of...